Header Logo

Connection

STEVEN I SHERMAN to Prognosis

Back to Details
This is a "connection" page, showing publications STEVEN I SHERMAN has written about Prognosis.
STEVEN I SHERMAN
Connection Strength
0.286
Prognosis
  1. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2017 09 01; 102(9):3591-3599.
    View in: PubMed
    Score: 0.041
  2. Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer. J Clin Endocrinol Metab. 2016 11; 101(11):4461-4467.
    View in: PubMed
    Score: 0.039
  3. Follicular cell-derived thyroid cancer. Nat Rev Dis Primers. 2015 12 10; 1:15077.
    View in: PubMed
    Score: 0.037
  4. Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis. Thyroid. 2015 Oct; 25(10):1097-105.
    View in: PubMed
    Score: 0.036
  5. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. Head Neck. 2008 Jul; 30(7):883-8.
    View in: PubMed
    Score: 0.022
  6. Glycemic control in diabetic patients improved overall lung cancer survival across diverse populations. JNCI Cancer Spectr. 2024 Sep 02; 8(5).
    View in: PubMed
    Score: 0.017
  7. Thyroid carcinoma. Lancet. 2003 Feb 08; 361(9356):501-11.
    View in: PubMed
    Score: 0.015
  8. Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine. J Clin Endocrinol Metab. 2018 10 01; 103(10):3698-3705.
    View in: PubMed
    Score: 0.011
  9. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions. Thyroid. 2018 10; 28(10):1301-1310.
    View in: PubMed
    Score: 0.011
  10. Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016 Sep; 17(9):1272-82.
    View in: PubMed
    Score: 0.010
  11. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. Thyroid. 2014 Jan; 24(1):35-42.
    View in: PubMed
    Score: 0.008
  12. Diagnosis and management of differentiated thyroid cancer using molecular biology. Laryngoscope. 2013 Apr; 123(4):1059-64.
    View in: PubMed
    Score: 0.008
  13. Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2011 Feb; 137(2):157-62.
    View in: PubMed
    Score: 0.007
  14. Thyroid carcinoma. J Natl Compr Canc Netw. 2010 Nov; 8(11):1228-74.
    View in: PubMed
    Score: 0.006
  15. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009 Nov; 19(11):1167-214.
    View in: PubMed
    Score: 0.006
  16. Four patients with cutaneous metastases from medullary thyroid cancer. Thyroid. 2008 Aug; 18(8):901-5.
    View in: PubMed
    Score: 0.006
  17. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004 Aug; 26(8):716-26.
    View in: PubMed
    Score: 0.004
  18. Prognostic factors in patients with H?rthle cell neoplasms of the thyroid. Cancer. 2003 Mar 01; 97(5):1186-94.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.